MapLight Therapeutics MPLT
NASDAQ MPLT
$9.82 +0.19 (+1.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

MapLight Therapeutics (MPLT) Cash & Equivalents (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) recorded Cash & Equivalents of $71.63 million in Q2 2026.

Analysis

MapLight Therapeutics (MPLT) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, MapLight Therapeutics reported Cash & Equivalents of $46.73 million, up 22.2% from FY2024.

  • Across earlier years, Cash & Equivalents came in at $38.25 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 MapLight Therapeutics 446.19 Mn 446.19 Mn - 71.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 71.63 Mn
Dec 31, 2025 46.73 Mn
Sep 30, 2025 64.15 Mn
Dec 31, 2024 38.25 Mn
API Access

MapLight Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MPLT&period=max&api_key=YOUR_API_KEY